In vitro studies demonstrate that TGF-β1-induced epithelial-mesenchymal transition (EMT) facilitates colorectal cancer (CRC) invasion and metastasis by reducing E-cadherin expression, enhancing Vimentin expression, and activating the TGF-β1/Smads signaling pathway. This evidence concerns the gene TGFB1 and colorectal carcinoma.